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Summary.-Five dihydrodiols derived from benz[a]anthracene (BA) and 4 dihydro-
diols derived from 7,12-dimethylbenz[a]anthracene (DMBA) have been tested, to-
gether with the parent hydrocarbons, for their abilities to induce mutations to
8-azaguanine resistance in V79 Chinese hamster cells and malignant transformation
in M2 mouse fibroblasts. The syn- and anti-isomers of benzLa]anthracene 8,9-diol
10,11-oxide were also tested for biological activity in these two systems. The non-K-
region 1,2- and 3,4-dihydrodiols of BA induced mutations but the non-K-region
8,9-dihydrodiol and the K-region 5,6-dihydrodiol were inactive as mutagens; none of
these BA diols transformed M2 mouse fibroblasts. The 3,4- and the 8,9-dihydrodiols
derived from 7,12-dimethylbenz[a]anthracene induced mutations in V79 cells and
malignant transformation in M2 mouse fibroblasts and both were more active than
the hydrocarbon itself. The K-region 5,6-dihydrodiol and the non-K-region 10,11-
dihydrodiol of DMBA were inactive in both test systems. The results are not incon-
sistent with other data suggesting that the metabolic activation of both BA and
DMBA occurs through conversion of the respective 3,4-dihydrodiols into the related
vicinal diol-epoxides, although other dihydrodiols may also be involved in vivo. Both
the BA diol-epoxides tested were mutagenic, but although the anti-isomer trans-
formed M2 fibroblasts, the syn-isomer was inactive.
A NUMBER ofapproaches have been used
to identify those non-K-region dihydro-
diols that are involved, probably through
the formation of the related vicinal diol-
epoxides, in the metabolic activation of
the polycyclic hydrocarbons. These
approaches have included enzyme-
catalysed reactions of dihydrodiols with
DNA (Borgen et al., 1973), chromato-
graphic studies on the hydrocarbon-
deoxyribonucleoside products formed in
cells or tissues treated with the parent
hydrocarbons (Baird & Brookes, 1973;
Sims et al., 1974; Jeffrey et al., 1977;
Tierney et al., 1977) and examinations of
the fluorescence spectral characteristics of
the DNA extracted from such cells and
tissues (Daudel et al., 1975; Vigny et al.,
1977a). Although the results of these
biochemical and biophysical investiga-
tions have often provided strong circum-
stantial evidence implicating one particu-
lar dihydrodiol, additional evidence that
this dihydrodiol is more biologically active
than other dihydrodiols derived from the
same hydrocarbon has usually been sought
from test systems in which dihydrodiols
are expected to be metabolically con-
verted in situ into the related vicinal diol-
epoxides. Such studies on mutagenicity
(Malaveille et al., 1975, 1977; Wislocki et
al., 1976) and on the abilities of non-K-
region dihydrodiols to induce malignant
transformation in mammalian cells (Mar-
quardt et al., 1976, 1977b) and to initiate
tumours in mouse skin (Chouroulinkov et
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al., 1976, 1977; Slaga et at., 1976; Levin et
at., 1976) have been useful in helping to
identify those dihydrodiols that are the
precursors of the vicinal diol-epoxides in-
volved in the metabolic activation of
benzo[a]pyrene and 7-methylbenz[a]an-
thracene. Attention has now been turned
towards the metabolic activation of other
hydrocarbons, and efforts are beinig made
to identify the dihydrodiols concerned in
the activation of, for example, benz[a]an-
thracene (BA) (Wood et at., 1976, 1977a),
7,12-dimethylbenz[a]anthracene (DMBA)
(Moschel et al., 1977; Vigny et al., 1977b;
Ivanovic et al., 1978) and 3-methylchol-
anthrene (King et al., 1977; Thakker et al.,
1978).
The weak carcinogen, benz[a]anthra-
cene (I), and the potent carcinogen, 7,12-
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dimethylbenz[a]anthracene (II), are
known to be converted into a variety of
K-region and non-K-region dihydrodiols
by rat-liver preparations (Boyland &
Sims, 1964, 1965; Sims, 1970; Tierney et
al., 1978b). In this paper the results of
comparative tests that have been carried
out on the activities of 5 trans-dihydro-
diols derived from BA and 4 trans-dihydro-
diols derived from DMBA in inducing
mutations to 8-azaguanine resistance in
V79 Chinese hamster cells (Chu & Malling,
I
I o... ,~-o
H
anti-Isomer of syn-lsomer of
a Diol-Epoxide a Diol-Epoxide
F'IG. The anti- and syn-isomers of a vicinal
diol-epoxide.
1968) and malignant transformation in
M2 mouse fibroblasts (Marquardt et al.,
1974) are described. The anti- and syn-
isomers (see Fig.) of a vicinal diol-epoxide
derived from benz[a]anthracene have also
been tested for biological activity.
MATERIALS AND METHODS
MateriaIs8.-N-Methyl-N'-nitro-N-nitroso-
guanidine (Aldrich Chemical Co., Milwaukee,
Wisc., U.S.A.), 8-azaguanine (Sigma Chemical
Co., St Louis, Mo., U.S.A.)-and tissue-culture
media (Eagle's basal medium and Dulbecco's
MEM, both supplemented with 10% heat-
inactivated foetal calf serum and penicillin-
streptomycin) (Grand Island Biological Co.,
Grand Island, N.Y., U.S.A.) were purchased.
Benz[a]anthracene and 7,12-dimethylbenz[a]-
anthracene (Sigma (London), Kingston-upon-
Thames, Surrey, U.K.) were purified by
recrystallization. trans - 1,2- Dihydro-1,2-di-
hydroxy - BA, trans - 3,4 - dihydro - 3,4 - dihy-
droxy-BA, trans-8,9-dihydro-8,9-dihydroxy-
BA, trans -10,11 - dihydro -10,11 - dihydroxy-
BA, trans-3,4-dihydro-3,4-dihydroxy-DMBA
trans-8,9-dihydro-8,9-dihydroxy-DMBA and
trans-10,11-dihydro-10,11-dihydroxy-DMBA
were prepared by oxidation of the parent
hydrocarbon (Tierney et al., 1978a, b, c) or by
synthesis (Lehr et al., 1977a) and were
characterized by their u.v., n.m.r. and mass
spectral characteristics. trans-5,6-Dihydro-5,
6-dihydroxy-BA (Boyland & Sims, 1964),
trans - 5,6 - dihydro - 5,6 - dihydroxy - DMBA
(Boyland & Sims, 1967) and (±) 8P,9a-
dihydroxy - I0oa,11Ix - epoxy - 8,9,10,11 - tetra -
hydro-BA (the anti-isomer) and (±) 8fl,9oc-
dihydroxy - lOf,ll,fl - epoxy - 8,9,10,11 - tetra-
hydro-BA (the syn-isomer) (Lehr et al., 1977b)
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were also prepared by published procedures.
V79 Chinese hamster cells were kindly pro-
vided by Dr E. H. Chu, Department of
Human Genetics, University of Michigan,
Ann Arbor, Michigan, U.S.A., and inbred
male C3H/HeJ mice were obtained from the
Jackson Laboratory, Bar Harbor, Maine,
U.S.A.
Mutagenesis in V79 Chinese hamster cells.-
V79 Chinese hamster cells were used to
determine chemically induced mutations.
These cells provide a model system for assay-
ing mutagenesis that was developed by Chu
& Malling (1968). The model uses a change
from 8-azaguanine (AZ) susceptibility to re-
sistance as a marker for mutagenesis. Before
use, the cells were cloned by ring isolation in
a medium containing thymidine, hypo-
xanthine, aminopterin, and glycine in order
to eliminate spontaneous AZr mutants, and
the mutagenesis assay was carried out as
previously described (Huberman et al., 1971).
Cytotoxicity was measured by plating 102
cells into 60mm dishes containing AZ-free
medium. The test compounds were added as
freshly prepared solutions in dimethyl sulph-
oxide 18 h later; after 3 h the contents ofthe
dishes were replaced with fresh AZ-free
medium. The culture dishes were incubated
for 6 to 8 days, the cells fixed and stained, and
the colonies counted. Cytotoxicity was ex-
pressed as the number of colonies in the
treated dishes as a percentage of those in the
controls. The average plating efficiency in the
control dishes was 89%. Mutagenicity was
measured by plating 5 x 104 cells into 60mm
dishes containing AZ-free medium. The cell
numbers were determined 18 h later using 2
dishes (usually 105 cells) and the remaining
dishes were treated for 3 h with a test com-
pound. The medium was then replaced with
fresh AZ-free medium without the test com-
pound, and the cells were incubated for an
additional 48 h. Thereafter, the dishes were
re-fed every 2 days with medium containing
AZ (20 ,ug/ml). Ten to 14 days after the initial
addition of AZ, the dishes were fixed and
stained, and the resistant colonies counted.
The mutation frequency was calculated per
105 survivors: the background spontaneous
mutation rate was 6-3 colonies/105 survivors.
The variations in compound-induced changes
in the plating efficiencies and the yields of
mutations in V79 cells are quite small and the
standard errors range between 3% and 7% of
the mean values.
Malignant transformation in M2 mouse
fibroblasts.-The M2 clone of mouse fibro-
blasts used to determine malignant trans-
formation was originally obtained from C3H
mouse prostate, and was established as a line
by procedures described by Chen & Heidel-
berger (1969). This clone is susceptible to
transformation by chemicals (Marquardt,
1973, 1976; Marquardt et al., 1974). In the
present work, cells were used between the
11th and 24th passages and the transforma-
tion assay was performed as previously re-
ported (Marquardt et al., 1974). In order to
estimate plating efficiency and to assay
transformation, 102 and 103 cells respectively
were plated into 60mm dishes, and after 24 h
the cultures were treated with freshly pre-
pared solutions of the test compounds in
dimethyl sulphoxide. After 24 h, the com-
pounds were removed by changing the media;
thereafter, the media was changed twice
weekly. After 7-14 days, the cells in the dishes
plated with 102 cells were fixed and stained,
and the colonies counted to determine plating
efficiency. After 56 days, the dishes plated
with 103 cells were fixed, stained and scored
for transformed, piled-up foci. The standard
errors for the yields of transformed foci/103
plated cells ranged between 5% and 21% of
the mean values.
In addition, in order to check the validity
of this transformation assay, piled-up foci of
morphologically transformed cells, areas of
the same dish with normal morphology, and
areas from control dishes were ring-isolated.
The isolated cells were passaged twice and
inoculated (106 cells) s.c. into inbred male
C3H/HeJ mice that were observed for 6
months for tumour development.
RESUJLTS AND DISCUSSION
Table I shows the results obtained when
BA and 7,12-DMBA and some of their
related dihydrodiols were tested for their
ability to induce mutations to AZ resist-
ance in V79 Chinese hamster cells and
malignant transformations in M2 mouse
fibroblasts. In the induction ofmutations,
the non-K-region 1,2- and 3,4-dihydro-
diols of BA were active, whereas the
K-region 5,6- and the non-K-region 8,9-
dihydrodiols were inactive; the 10,11-
dihydrodiol was not tested in this systemMETABOLIC ACTIVATION OF BA AND DMBA
TABLE I.-Mutagenesis and malignant transformation in mammalian cells by dihydrodiols
derived from benz[a]anthracene (BA) and 7,12-dimethylbenz[a]anthracene (DMBA)*
Mutagenesis in V79 celist
, A-
Compound
Dimethylsulphoxide §
N-Methyl-N'-nitro-N-
nitrosoguanidine§
BA
DMBA
tran8-1,2-Dihydro-1,2-
dihydroxy BA**
tran8-3,4-Dihydro-3,4-
dihydroxy BA
tran8-3,4-Dihydro-3,4-
dihydroxy-DMBA
trans-5,6-Dihydro-5,6-
dihydroxy BA
trans-5,6-Dihydro-5,6-
dihydroxy-DMBA
tran8-8,9-Dihydro-8,9-
dihydroxy-BA
tran8-8,9-Dihydro-8,9-
dihydroxy-DMBA
tran8-10,11-Dihydro-
10,11-dihydroxy-BA
tran8-10,11-Dihydro-
10,11-dihydroxy-DMBA
Concentration
(Gg/ml)
0.5%
04
1-0
10-0
0-25
1-0
1-2
2-5
5*0
10-0
2-5
5*0
10-0
0-12
0-25
0 5
1-0
2-5
5 0
10-0
1-0
5 0
10-0
2-5
5-0
10-0
0-25
0-5
1-0
2-5
5-0
10-0
0-25
0-5
1.0
Plating
efficiency
(%)
84
31
82
70
63
39
99
95
89
55
93
84
56
67
58
50
43
85
74
59
80
73
57
57
54
53
62
45
32
76
68
44
AZr
colonies/105
survivors
2-7
294-1
4-5
5-4
3 0
4-4
13-0
16-6
17-5
41-5
16-4
24-5
56-5
5-7
19-8
29-8
44-1
2-6
1-3
0
2-0
0 9
0
1-5
1-6
1-6
1-9
20-5
42-5
6-3
5-6
4.9
Transformation in M2 cellst
Plating Transformed Transformed
efficiency foci/dishes foci/103
(%) treated survivors
31 0/9 0
21 10/9 5.3
32
29
26
24
44
40
37
10
50
38
12
31
26
25
15
44
42
40
28
28
20
44
39
30
26
22
7
44
37
29
30
26
11
0/22
8/22
9/8
19/11
0/3
0/12
0/11
1/19
0/10
0/11
0/12
3/5
9/10
26/8
20/9
0/12
0/12
0/12
0/10
0/10
0/10
0/12
0/12
0/12
4/4
15/5
11/6
0/12
0/12
0/12
0/8
0/12
0/11
0
1-3
4-3
7-2
0
0
0
0-5
0
0
0
1-9
3.5
13-0
14-3
0
0
0
0
0
0
0
0
0
3-8
13-6
26-2
0
0
0
0
0
0
* Composite results from 2-4 separate experiments.
t Cells were grow* in media containing the test compound for 3 h.
t Cells were growh in media containing the test compound for 24 h.
§ These data serve as controls for the experiments using DMBA or its derivatives. The control data for
the experiments using BA and its derivatives are given in Table II.
** The corresponding 1,2-dihydrodiol of DMBA was not available for testing.
because of a shortage of material at the
time the experiments were carried out. In
contrast, the non-K-region 8,9-dihydro-
diol ofDMBA, as well as the corresponding
3,4-dihydrodiol, were active. The K-region
5,6-dihydrodiol and the non-K-region
10,11-dihydrodiol were inactive: the re-
lated 1,2-dihydrodiol was not available
for testing. Both the parent hydrocarbons
were inactive in this test system, pre-
sumably because of the low metabolic
capabilities of V79 cells.
In the M2 cells, both parent hydrocar-
bons showed some activity, although BA
was much less active than DMBA, even at
the higher concentrations used for the
former compound. None of the 5 dihydro-
diols ofBA showed significant activities in
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the induction of malignant transforma-
tion, whereas at a dose level of 1 jug/ml
both the 3,4- and 8,9-dihydrodiols of
DMBA appeared to be more active than
the parent hydrocarbon, if the frequency
of malignant transformation is considered
in terms of the numbers of surviving cells.
It should be noted, however, that in the
experiments carried out with BA deriva-
tives, the M2 cells showed unusually high
plating efficiencies that were not apparent
in the experiments performed later with
the DMBA derivatives. The increased
plating efficiencies were most probably due
to a particular batch of foetal calf serum
that supported the growth of the M2 cells
especially well.
Morphologically transformed cells were
also tested for their abilities to induce
tumours in isologous, unirradiated mice.
Five weeks after the injection into C3H/
HeJ mice (3 mice/clone) of cells (106 cells)
from 2 clones transformed by the 3,4-
dihydrodiol derived from DMBA, all 6
animals had developed malignant fibro-
sarcomas as diagnosed by histological
examination. The tumours did not meta-
stasize. Six mice that received injections
of cells from control cultures or of cells
with normal morphology from treated
dishes did not develop tumours.
The mutagenic activity shown by the
3,4-dihydrodiol ofBA is in agreement with
results ofother studies, where the diol was
active as a mutagen both in V79 cells
(Slaga et al., 1978) and in Salmonella
typhimurium TA100 (Wood et al., 1976)
in the presence of mono-oxygenase sys-
tems. However, the mutagenic activity
shown by the 1,2-dihydrodiol was un-
expected since it was not found to be
active by other workers either in V79 cells
(Slaga et al., 1978) or in S. typhimurium
(Wood et al., 1976). In the present work,
however, the mutagenicity studies in V79
cells were carried out in the absence ofthe
secondary cultures of embryo cells often
used to augment the low metabolizing
abilities of the V79 cells. The high muta-
genic activity of the 3,4-dihydrodiol of
DMBA is in accord with its high micro-
some-mediated mutagenic activity in S.
typhimurium TA100 (Malaveille et al.,
1978). The high mutagenic activity shown
by the 8,9-dihydrodiol of DMBA is per-
haps unexpected, since the diol-epoxide
formed from this diol by metabolism is not
a vicinal bay-region diol-epoxide. How-
ever, the 8,9-dihydrodiol showed some
mutagenic activity in S. t-yphimurium
(Malaveille et al., 1978) and the related
8,9-dihydrodiol of 7-methylbenz[a]anthra-
cene was active in V79 cells (Marquardt
et al., 1977b).
The inability of the 3,4-dihydrodiol of
BA to induce malignant transformation
in M2 cells is surprising, since BA itself
induced some transformations and the
diol is highly active, both as an initiator of
tumours on mouse skin (Wood et al., 1977b;
Slaga et al., 1978) and as an inducer of
tumours in newborn mice (Wislocki et al.,
1976). On the other hand, the 3,4-dihydro-
diol of DMBA, which induces malignant
transformation in M2 cells, also acts as an
initiator of tumours on mouse skin (I.
Chouroulinkov, personal communication).
The 8,9-dihydrodiol of DMBA also in-
duces malignant transformations in M2
cells, in agreement with earlier observa-
tions (Marquardt et al., 1976), where both
this diol and the 8,9-dihydrodiol of 7-
methylbenz[a]anthracene were active in
M2 cells. It is not yet known why these
two diols are biologically active since
neither compound can give rise to a bay-
region diol-epoxide of the type on meta-
bolism described by Jerina et al. (1976).
Table II shows the results of a short
study on the biological activities of the 2
isomeric 8,9-dihydrodiol-10,11-epoxides
of BA. In V79 cells, the anti-isomer was
more active as a mutagen than the syn-
isomer, and in M2 cells the anti-isomer was
active in inducing malignant transforma-
tion, whilst the syn-isomer was inactive.
Wood et al. (1977a) similarly showed that
the anti-isomer of this diol-epoxide is
more active than the syn in inducing
mutations in V79 cells. The anti-isomer
of the 7,8-dihydrodiol-9,10-epoxide of
benzo[a]pyrene is also more active thanMETABOLIC ACTIVATION OF BA AND DMBA 545
TABLE II.-Mutagenesis and malignant transformation in mammalian cells by diol-
epoxides of benz[a]anthracene BA*
Mutagenesis in V79 cellst Transformation in M2 cellst
Plating AZr Plating Transformed Transformed
Concentration efficiency colonies/105 efficiency foci/dishes foci/103
Compound (,ug/ml) (%) survivors (%) treated survivors
Dimethylsulphoxide§ 0 5% 95 9-9 51 0/29 0
N-Methyl-N'-nitro-N- 0-2 74 85-1 32 23/24 3.0
nitrosoguanidine§ 0-4 56 143-2 26 25/19 5-1
(±)-8P, 9a-Dihydroxy-10fl, 0-6 56 44-1 - -
11$-epoxy-8,9,10,11- 1-2 50 69-9 47 0/6 0
tetrahydro BA (syn- 2-5 49 68-3 49 0/6 0
isomer) 5 0 48 69-4 30 0/6 0
(±)-8f,99a-Dihydroxy- 0-6 57 116-7 - - -
lOa,lla-epoxy-8,9,10,11- 1-2 48 126-6 26 1/6 0 9
tetrahydro BA (anti- 2-5 41 156-0 12 4/6 5-6
isomer) 5 0 35 187-7 6 4/6 11-3
* Composite results from 2 separate experiments.
t Cells were grown in media containing the test compound for 3 h.
t Cells were grown in media containing the test compound for 24 h.
§ These data serve as controls for the experiments with BA and its derivatives shown in Table I.
the syn in inducing transformations in M2
cells (Marquardt et al., 1977a). When the
8,9-dihydrodiol of BA is metabolized by a
rat-livermicrosomalfraction, a8,9-dihydro-
diol-10,1 -oxide was detected as a metabo-
lite (Booth & Sims, 1974); this oxide has
now been shown to be the anti-isomer
(P. Sims, unpublished observations).
BA and DMBA are metabolized by rat-
liver microsomal fractions to a number of
dihydrodiols (Tierney et al., 1978c), the
major products being the 5,6- and 8,9-
dihydrodiols. Smaller amounts of the
10,11-dihydrodiols are formed from both
hydrocarbons, but whereas BA yields a
little 1,2-dihydrodiol, no 1,2-dihydrodiol
is formed from DMBA. In contrast,
some 3,4-dihydrodiol is formed from
7,12-DMBA but only trace amounts
of the corresponding dihydrodiol from
benz[a]anthracene. However, Levin et al.
(1978) suggest that, with BA, an isomer of
the 3,4-dihydrodiol-1,2-oxide is the ulti-
mate carcinogen. The species derived from
this hydrocarbon that binds to the DNA
or hamster embryo cells was originally
thought to be one of the isomers of the
8,9-dihydrodiol-10,11-epoxide tested here
(Swaisland et al., 1974), but this now seems
less likely in view of more recent results.
The particular diol-epoxides derived
from DMBA that are involved in DNA
binding have not yet been identified with
certainty, but fluorescence studies (Vigny
et al., 1977b; Moschel et al., 1977; Ivanovic
et al., 1978) on the DNA of mouse skin or
cells in culture have implicated products
formed on the 1,2,3,4-ring of the hydro-
carbon. Assuming that reactions with
DNA are related to biological activity, the
present results and some others (Mala-
veille et al., 1978) suggest that these pro-
ducts are one or both ofthe isomers ofthe
3,4-dihydrodiol-1,2-epoxide.
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